Peptide Therapy Vita 10 Therapy The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptide Therapy Dallas BPC 157, Sermorelin & More Injectable and Topical Peptides in Aesthetic Medicine Mechanisms, Clinical Applications, and Future Potential PRIME Journal